Life AI Net
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
Hot
ログイン
日本語
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ホーム
アーカイブ
計算ツール
ディレクトリ
ニュースレター
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
ログイン
ホーム
アーカイブ
計算ツール
ディレクトリ
More
ライブ
FierceBiotech
When Spray Drying Falls Short: A Faster Path Forward
FierceBiotech
Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win
FierceBiotech
Roche boosts diagnostics offerings with $595M Saga buyout
FierceBiotech
Lilly picks up another in vivo CAR-T company with Kelonia buyout worth up to $7B
FierceBiotech
Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody
Moderna
What's Pushing Moderna Stock Higher Today? - Benzinga
Novo Nordisk
Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Abbott
Diane Abbott criticises Keir Starmer over Peter Mandelson vetting process - Sky News
Intuitive Surgical
Intuitive Surgical Q1 2026 Earnings Preview (ISRG:NASDAQ) - Seeking Alpha
Thermo Fisher
Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings (NYSE:TMO) - Seeking Alpha
Thermo Fisher
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today - Benzinga
BioWorld
Biggest gainers and losers for April 13-17, 2026
FierceBiotech
When Spray Drying Falls Short: A Faster Path Forward
FierceBiotech
Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win
FierceBiotech
Roche boosts diagnostics offerings with $595M Saga buyout
FierceBiotech
Lilly picks up another in vivo CAR-T company with Kelonia buyout worth up to $7B
FierceBiotech
Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody
Moderna
What's Pushing Moderna Stock Higher Today? - Benzinga
Novo Nordisk
Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Abbott
Diane Abbott criticises Keir Starmer over Peter Mandelson vetting process - Sky News
Intuitive Surgical
Intuitive Surgical Q1 2026 Earnings Preview (ISRG:NASDAQ) - Seeking Alpha
Thermo Fisher
Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings (NYSE:TMO) - Seeking Alpha
Thermo Fisher
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today - Benzinga
BioWorld
Biggest gainers and losers for April 13-17, 2026
アーカイブ
検索
検索
最新
古い順
クリア
@BioPharma Dive
合計
8
情報源
BioPharma Dive
検索
Roche
BioPharma Dive
2026年4月10日
RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders
BioPharma Dive
2026年3月20日
Roche stops work on experimental SMA drug
BioPharma Dive
2026年3月9日
Roche’s prized breast cancer pill fails closely watched study
BioPharma Dive
2026年3月6日
Roche, Zealand shares fall on ‘undifferentiated’ obesity drug results
BioPharma Dive
2026年3月2日
Roche pill succeeds in another MS study, but approval questions linger
BioPharma Dive
2026年2月20日
Roche gets FDA decision date on closely watched breast cancer drug
BioPharma Dive
2026年2月9日
Lilly bets again on China drugs; Roche showcases MS data
BioPharma Dive
2026年1月27日
Roche, trailing in obesity, showcases new data for GLP-1 shot